Susquehanna International Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-174,100
Closed -$850K 12675
2025
Q1
$850K Sell
174,100
-76,400
-30% -$459K ﹤0.01% 7664
2024
Q4
$2.09M Buy
250,500
+248,285
+11,209% +$2.17M ﹤0.01% 5226
2024
Q3
$23K Sell
2,215
-10,620
-83% -$177K ﹤0.01% 11595
2024
Q2
$252K Sell
12,835
-15,905
-55% -$319K ﹤0.01% 9842
2024
Q1
$736K Sell
28,740
-14,035
-33% -$360K ﹤0.01% 7595
2023
Q4
$1.18M Buy
42,775
+24,015
+128% +$1.46M ﹤0.01% 6582
2023
Q3
$1.14M Buy
18,760
+17,775
+1,805% +$1.25M ﹤0.01% 6340
2023
Q2
$64.8K Sell
985
-3,350
-77% -$245K ﹤0.01% 11219
2023
Q1
$276K Buy
4,335
+3,785
+688% +$432K ﹤0.01% 9904
2022
Q4
$76.1K Sell
550
-5,335
-91% -$752K ﹤0.01% 11174
2022
Q3
$745K Buy
5,885
+3,050
+108% +$345K ﹤0.01% 7400
2022
Q2
$235K Buy
2,835
+1,500
+112% +$116K ﹤0.01% 10221
2022
Q1
$129K Sell
1,335
-1,300
-49% -$172K ﹤0.01% 11711
2021
Q4
$526K Sell
2,635
-14,812
-85% -$3.5M ﹤0.01% 9048
2021
Q3
$4.32M Buy
17,447
+14,984
+608% +$4.28M ﹤0.01% 4224
2021
Q2
$1.02M Buy
2,463
+834
+51% +$330K ﹤0.01% 7702
2021
Q1
$636K Sell
1,629
-6,269
-79% -$3.09M ﹤0.01% 8914
2020
Q4
$4.43M Sell
7,898
-1,142
-13% -$724K ﹤0.01% 3614
2020
Q3
$6.32M Sell
9,040
-4,200
-32% -$3.28M ﹤0.01% 2764
2020
Q2
$10.5M Buy
13,240
+8,446
+176% +$6.37M ﹤0.01% 2081
2020
Q1
$2.85M Sell
4,794
-11,472
-71% -$11.2M ﹤0.01% 3374
2019
Q4
$18.5M Sell
16,266
-2,362
-13% -$2.57M 0.01% 1495
2019
Q3
$22.2M Buy
18,628
+494
+3% +$754K 0.01% 1261
2019
Q2
$29.9M Sell
18,134
-8,500
-32% -$14.7M 0.01% 1011
2019
Q1
$54.3M Sell
26,634
-32,825
-55% -$57.8M 0.02% 584
2018
Q4
$76.4M Buy
59,459
+21,500
+57% +$33M 0.03% 453
2018
Q3
$71.8M Buy
37,959
+12,344
+48% +$25.5M 0.02% 542
2018
Q2
$52.1M Buy
25,615
+2,393
+10% +$5.45M 0.02% 670
2018
Q1
$51.4M Buy
23,222
+487
+2% +$1.24M 0.02% 649
2017
Q4
$52.5M Sell
22,735
-2,764
-11% -$5.61M 0.02% 672
2017
Q3
$45.4M Sell
25,499
-6,238
-20% -$8.72M 0.02% 686
2017
Q2
$43.2M Buy
31,737
+9,380
+42% +$11.3M 0.02% 686
2017
Q1
$26.3M Sell
22,357
-1,289
-5% -$1.31M 0.01% 884
2016
Q4
$18.9M Buy
23,646
+8,661
+58% +$6.88M 0.01% 1092
2016
Q3
$13.2M Buy
14,985
+1,382
+10% +$1M 0.01% 1314
2016
Q2
$7.63M Buy
13,603
+3,104
+30% +$1.76M ﹤0.01% 1706
2016
Q1
$5.78M Sell
10,499
-6,948
-40% -$4.27M ﹤0.01% 2122
2015
Q4
$14.5M Buy
17,447
+5,605
+47% +$5.6M 0.01% 1418
2015
Q3
$13.1M Sell
11,842
-4,123
-26% -$7.52M 0.01% 1582
2015
Q2
$34.8M Sell
15,965
-3,459
-18% -$7.05M 0.01% 900
2015
Q1
$30.4M Buy
19,424
+9,064
+87% +$12M 0.01% 924
2014
Q4
$12.3M Buy
10,360
+5,635
+119% +$3.77M ﹤0.01% 1798
2014
Q3
$2.2M Buy
4,725
+3,073
+186% +$1.42M ﹤0.01% 4444
2014
Q2
$825K Buy
+1,652
New +$530K ﹤0.01% 6455

Other funds holding BLUE

Susquehanna International Group's BLUE Position: Q2 2025 in Review

Susquehanna International Group sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 56,588 shares — an estimated $276K sold.

Susquehanna International Group first reported a position in BLUE in Q1 2014 and held it in 44 quarters. The position peaked at $53M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Susquehanna International Group reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 56,588 bluebird bio shares in Q2 2025, an estimated $276K.
  • Susquehanna International Group first reported a position in bluebird bio in Q1 2014 and held it in 44 quarters.
  • Susquehanna International Group's bluebird bio position peaked at $53M in Q2 2018.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.